FINWIRES · TerminalLIVE
FINWIRES

Dolby Laboratories Fiscal Q3 Adjusted Earnings, Revenue Fall

By

Dolby Laboratories (DLB) reported fiscal Q3 adjusted earnings Thursday of $0.69 per diluted share, down from $0.78 a year earlier.

Three analysts polled by FactSet expected $0.67.

Revenue in the three months ended June 26 fell to $305 million from $315.5 million a year earlier.

Four analysts projected $312 million.

Dolby expects fiscal Q4 adjusted EPS of $1.13 to $1.28 on revenue of $362 million to $392 million. Four analysts project EPS of $1.14 on revenue of $351.9 million.

The company expects fiscal 2026 adjusted EPS of $4.25 to $4.40 on revenue of $1.41 billion to $1.44 billion. The previous forecast was EPS of $4.30 to $4.45 on revenue of $1.40 billion to $1.45 billion.

Four analysts project EPS of $4.31 on revenue of $1.41 billion.

Dolby shares fell 1.5% in after-hours trading.

Related Articles

Wire

Houlihan Lokey Fiscal Q1 Adjusted Earnings, Revenue Fall; Shares Drop After Hours

Houlihan Lokey (HLI) reported fiscal Q1 adjusted earnings late Wednesday of $1.35 per diluted share, down from $2.14 a year earlier.Analysts polled by FactSet expected $1.64.Revenue in the three months ended June 30 fell to $511 million from $605 million a year earlier.Analysts expected $602.4 million.Houlihan Lokey shares fell 6.6% in after-hours trading.

$HLI
Wire

Four Corners Property Trust Q2 AFFO, Revenue Rise

Four Corners Property Trust (FCPT) reported Q2 adjusted funds from operations late Wednesday of $0.45 per diluted share, up from $0.44 a year earlier.Analysts polled by FactSet expected $0.45.Revenue in the quarter ended June 30 rose to $78.4 million from $72.8 million a year earlier.Four analysts expected $79 million.The company's shares rose 2% in after-hours trading.

$FCPT
Wire

Corcept Therapeutics Q2 Earnings, Revenue Rise; Shares Jump After Hours

Corcept Therapeutics (CORT) reported Q2 earnings late Wednesday of $0.36 per diluted share, up from $0.29 a year earlier.Analysts polled by FactSet expected $0.02.Revenue for the three months ended June 30 rose to $256.1 million from $194.4 million a year earlier.Analysts expected $221.1 million.The company boosted full-year revenue guidance to $1.1 billion to $1.2 billion from the prior forecast of $950 million to $1.05 billion.Analysts project $999.5 million.Corcept shares jumped 18% in after-hours trading.

$CORT